Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3667-3677

  Wang, Wenrui ^a   Zhu, Rongrong ^a   Xie, Qian ^a   Li, Ang ^a   Xiao, Yu ^a   Li, Kun ^a   Liu, Hui ^b   Cui, Daxiang ^c   Chen, Yihan ^a   Wang, Shilong ^a  

^a TONGJI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Airway hyperresponsiveness; Curcumin; Pharmacokinetics; Solid lipid nanoparticles

Indexed keywords

CURCUMIN; INTERLEUKIN 13; INTERLEUKIN 4; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG ENTRAPMENT EFFICIENCY; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG LUNG LEVEL; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMA CONCENTRATION-TIME CURVE; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; SURFACE CHARGE; SUSTAINED DRUG RELEASE; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CURCUMIN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; HISTOCYTOCHEMISTRY; INTERLEUKIN-13; INTERLEUKIN-4; LIPIDS; LUNG; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; OVALBUMIN; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA; MUS; RATTUS;

EID: 84870362982     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S30428     Document Type: Article

References (47)

1. Yin LM, Jiang GH, Wang Y, etal. Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture. J Biomed Sci. 2009;16(46): 1-13.
2. Ray A, Cohn L. Th2cells and GATA-3in asthma: new insights into the regulation of airway inflammation. J Clin Invest. 1999;104(8):985-993.
3. Yin LM, Jiang GH, Wang Y, etal. Serial analysis of gene expression in a rat lung model of asthma. Respirology. 2008;13(7):972-982.
4. Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M, Johnston SL. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther. 2009;121(1):1-13.
5. Inapagolla R, Guru BR, Kurtoglu YE, Gao X, Lieh-Lai M, etal. In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation. Int J Pharm. 2010;399(1-2): 140-147.
6. Strehle EM. Long-term management of children with neuromuscular disorders. J Pediatr (Rio J). 2009;85(5):379-384.
7. Matsuo Y, Ishihara T, Ishizaki J, Miyamoto K, Higaki M, Yamashita N. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol. 2009;260(1):33-38.
8. Butoescu N, Seemayer CA, Foti M, Jordan O, Doelker E. Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials. 2009;30(9): 1772-1780.
9. Lee JH, Kim JW, Ko NY, etal. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J Allergy Clin Immunol. 2008;121(5): 1225-1231.
10. Tsai YM, Chien CF, Lin LC, Tsai TH. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm. 2011;416(1):331-338.
11. Suzuki M, Nakamura T, Iyoki S, etal. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull. 2005;28(8):1438-1443.
12. Moon DO, Kim MO, Lee HJ, etal. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochem Biophys Res Commun. 2008;375(2):275-279.
13. Ram A, Das M, Ghosh B. Curcumin attenuates allergen-induced airway hyper-responsiveness in sensitized guinea pigs. Biol Pharm Bull. 2003;26(7):1021-1024.
14. Oh SW, Cha JY, Jung JE, etal. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition. J Ethnopharmacol. 2011;136(3):414-421.
15. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-818.
16. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 1999;27(4):486-494.
17. Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 2007;595:453-470.
18. Farboud ES, Nasrollahi SA, Tabbakhi Z. Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies. Int J Nanomedicine. 2011;6:611-617.
19. Xie S, Pan B, Shi B, etal. Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm. Int J Nanomedicine. 2011;6:2367-2374.
20. Mulik RS, Monkkonen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 2010;398(1-2):190-203.
21. Kakkar V, Kaur IP. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol. 2011;49(11):2906-2913.
22. Luo CF, Yuan M, Chen MS, etal. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm. 2011;410(1-2):138-144.
23. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002;79(1-3):123-135.
24. Yin LM, Li HY, Zhang QH, etal. Effects of S100A9in a rat model of asthma and in isolated tracheal spirals. Biochem Biophys Res Commun. 2010;398(3):547-552.
25. Gueders MM, Balbin M, Rocks N, et al. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J Immunol. 2005;175(4):2589-2597
26. Jain A, Agarwal A, Majumder S, etal. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release. 2010;148(3):359-367.
27. Wang X, Xu W, Kong X, etal. Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res. 2009; 10(66):1-8.
28. Wang X, Xu W, Mohapatra S, etal. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet Vaccines Ther. 2008;6(7):1-9.
29. Han B, Guo J, Abrahaley T, etal. Adverse effect of nano-silicon dioxide on lung function of rats with or without ovalbumin immunization. PLoS One. 2011;6(2):e17236.
30. Park HJ, Lee CM, Jung ID, etal. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int Immunopharmacol. 2009;9(3):261-267.
31. Lee MY, Seo CS, Ha H, etal. Protective effects of Ulmus davidiana var. japonica against OVA-induced murine asthma model via upregulation of heme oxygenase-1. J Ethnopharmacol. 2010;130(1):61-69.
32. Kurup VP, Barrios CS, Raju R, Johnson BD, Levy MB, Fink JN. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy. 2007;5(1):1-12.
33. Kuo YC, Liang CT. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials. 2011;32(12):3340-3350.
34. Lee MK, Lim SJ, Kim CK. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials. 2007;28(12):2137-2146.
35. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597-6611.
36. Hu FX, Neoh KG, Kang ET. Synthesis and in vitro anti-cancer of tamoxifen-loaded magnetite/PLLA composite 2006;27(33):5725-5733.
37. Misra R, Acharya S, Dilnawaz F, Sahoo SK. Sustained antibacterial activity of doxycycline-loaded poly(D, L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles. Nanomedicine (Lond). 2009;4(5):519-530.
38. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105-114.
39. Zhang C, Qu G, Sun Y, Wu X, etal. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials. 2008;29(9):1233-1241.
40. Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release. 2005;107(2):215-228.
41. Gao Y, Xu P, Chen L, Li Y. Prostaglandin E1 encapsulated into lipid nanoparticles improves its anti-inflammatory effect with low side-effect. Int J Pharm. 2010;387(1-2):263-271.
42. Zhang DR, Tan TW, Gao L. Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo. Nanotechnology. 2006;17:5821-5828.
43. Xiang QY, Wang MT, Chen F, etal. Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch Pharm Res. 2007;30(4):519-525.
44. Du B, Li Y, Li X, Chen C, Zhang Z. Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes. Int J Pharm. 2010;384(1-2):140-147.
45. Brusasco V, Crimi E. Methacholine provocation test for diagnosis of allergic respiratory diseases. Allergy. 2001;56(12):1114-1120.
46. Lee M, Kim S, Kwon OK, Oh SR, Lee HK, Ahn K. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol. 2009;9(4):418-424.
47. Therien AG, Bernier V, Weicker S, etal. Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma. Am J Respir Cell Mol Biol. 2008;39(1):26-35.